The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,435.00
Bid: 1,454.00
Ask: 1,456.00
Change: -5.00 (-0.35%)
Spread: 2.00 (0.138%)
Open: 1,440.00
High: 1,474.00
Low: 1,435.00
Prev. Close: 1,440.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: UK's Spain Travel Rules Cause Headache For FTSE

Mon, 27th Jul 2020 11:59

(Alliance News) - The FTSE 100 continued to drag its heels at midday on Monday, hampered as London-listed travel stocks were dealt a blow by the UK reimposing quarantine measures on travellers returning from the holiday hotspot of Spain.

This was offsetting a strong session for gold miners, buoyant as the price of the precious metal eyed the USD2,000 mark amid a weak dollar.

The FTSE 100 index was down 9.13 points, or 0.2%, at 6,114.69 on Monday at midday. The mid-cap FTSE 250 index was down 73.92 points, or 0.4%, at 17,190.92. The AIM All-Share index was up 0.4%, however, at 887.35.

The Cboe UK 100 index was down 0.1% at 609.54. The Cboe 250 was down 0.7% at 14,593.54 and the Cboe Small Companies down 0.6% at 9,095.21.

In mainland Europe, the CAC 40 in Paris was down 0.1%, but the DAX 30 in Frankfurt was up 0.3% Monday afternoon.

Breaking from Europe, stocks in the US are on course for a positive start to the week, with the Dow Jones called up 0.4%, the S&P 500 up 0.5% and the Nasdaq up 0.8%.

In contrast to US equity markets, however, the US dollar was battered on Monday.

"The thing that's changed in the last few days is that it's not just gold which has gone up against the dollar, but almost everything. That's partly driven by a sense that the US is having a harder time controlling the virus than others, which will see the US economy under-perform," said Kit Juckes, strategist at SocGen.

Gold continued its breakout on Monday, quoted at USD1,934.57 an ounce at midday from USD1,900.17 on Friday. The precious metal hit a record high of USD1,944.36 an ounce in the early hours of Monday.

The US on Sunday recorded 55,187 new coronavirus cases in 24 hours, Johns Hopkins University reported in its real-time tally. This brings the total caseload to over 4 million.

An additional 518 deaths brought the overall death toll to 146,909.

After a drop in infection rate in the late spring, the US has seen a recent surge in Covid-19 cases, particularly in southern and western states such as California, Texas, Alabama and Florida.

The last time the daily number of new cases clocked in below 60,000 was almost two weeks ago, on July 13. Scientists agree that an increase in death rates follows the spike in infections by three to four weeks.

The daily death toll for the past four days exceeded 1,000.

The dollar was sharply lower against majors on Monday. Sterling was quoted at USD1.2866 on Monday, higher than USD1.2786 at the London equities close on Friday and reaching levels last seen in March.

The euro traded at USD1.1727 midday Monday, higher than USD1.1635 late Friday and still trading around its best price in two years. Against the yen, the dollar was quoted at JPY105.26, down versus JPY105.85.

Brent oil was trading at USD43.42 a barrel on Monday, up on USD43.06 late Friday.

In London, gold miners were the top blue-chip performers as they chased the price of the precious metal. Polymetal International was up 6.3% and Fresnillo up 3.3%.

Mid-cap producers were also higher, with Hochschild up 5.5% and Centamin up 5.1%.

Back in the FTSE 100, International Consolidated Airlines remained the biggest loser, shedding 7.6% after the UK's reintroduction of strict quarantine rules on travellers returning from Spain in the midst of the summer holidays.

Ministers announced on Saturday that holidaymakers who had not returned from Spain and its islands by midnight would be forced to quarantine for 14 days after Covid-19 second wave fears saw the popular holiday destination struck off the UK's safe list.

The Foreign Office guidance advising against all but essential travel to mainland Spain does not include the islands, but ministers opted to apply blanket quarantine arrangements across the Spanish territories.

The quick turnaround even caught out UK Transport Secretary Grant Shapps, who is currently in Spain for his summer break and will join thousands of others in being forced to self-isolate for a fortnight on his return to Britain.

Russ Mould, investment director at AJ Bell, commented: "The market is now pricing in the risk of restrictions on more countries and thus raising the potential for earnings estimates to be downgraded once again for travel-related industries."

Other travel stocks were lower on the UK's reimposed rules for the holiday hotspot. TUI shares slumped 11% and easyJet was also 11% lower.

Ryanair shares dipped 4.4%. The budget airline swung to a loss of GBP185 million in the first quarter ended June 30 from a net profit of GBP243 million a year ago.

The company saw 99% of its fleet grounded from mid-March to the end of June due to travel restrictions caused by Covid-19. Passengers fell to 500,000 in the quarter from 41.9 million a year ago.

"The past quarter was the most challenging in Ryanair's 35-year history. Covid-19 grounded the group's fleet for almost 4 months as EU governments imposed flight or travel bans and widespread population lockdowns," Ryanair said.

The Irish airline added that its "biggest fear" right now is a second wave of Covid-19 infections across Europe in late autumn, when the annual flu season starts.

In the FTSE 250, Kainos shares surged 20% after saying it will make a special dividend payout as the IT provider reported "resilience" in its trading so far this financial year.

Kainos, which had opted not to make a final payout for the financial year ended March 31, will release a special dividend of 6.7 pence. It added that it also expects to return to its usual cycle of paying an interim and final payout.

"The resilience in our business has been driven by our long-term relationships with our customers, by on-going demand within the NHS, Public Sector and Workday segments and by our diversification of revenues across customers, end markets and geographic regions," Kainos said.

Despite Covid-19, it expects annual revenue and adjusted profit to be "well ahead" of current consensus forecasts.

Elsewhere in London, Indivior shares continued where they left off on Friday, surging 32%.

On Friday, Indivior said it will part with USD600 million to resolve criminal charges in the US related to its Suboxone film opioid dependence medication. Indivior ended Friday's session 38% higher, meaning the stock has surged 82% since the news of its US settlement.

Jefferies raised the pharmaceutical firm to Buy from Hold on Monday.

To come in Monday's economic calendar are US durable goods orders at 1330 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Feb 2022 07:49

LONDON MARKET PRE-OPEN: Franchise Brands buys fellow AIM firm Filta

(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.

Read more
16 Feb 2022 07:05

Indivior considers US listing after returning to profit

(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.

Read more
9 Feb 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
28 Jan 2022 16:22

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

Read more
28 Jan 2022 14:53

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Read more
28 Jan 2022 09:02

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Read more
28 Jan 2022 07:55

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
10 Nov 2021 12:28

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

Read more
10 Nov 2021 10:12

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Read more
10 Nov 2021 08:07

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
28 Oct 2021 13:23

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Read more
28 Oct 2021 12:17

Indivior lifts FY guidance as Q3 profits, revenue jump

(Sharecast News) - Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.

Read more
24 Oct 2021 17:12

Sunday share tips: Light Science Technologies, Indivior

(Sharecast News) - The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.